These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 8913713)
21. Calcium channel blockers in the treatment of disease. Elmslie KS J Neurosci Res; 2004 Mar; 75(6):733-41. PubMed ID: 14994334 [TBL] [Abstract][Full Text] [Related]
22. Calcium channel antagonists. What do the second-generation agents have to offer? Salerno SM; Zugibe FT Postgrad Med; 1994 Jan; 95(1):181-90. PubMed ID: 8278298 [TBL] [Abstract][Full Text] [Related]
23. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials]. Oparil S; Bakir SE Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856 [TBL] [Abstract][Full Text] [Related]
24. [Advance in calcium channel blockers relaxing corpus cavernosum smooth muscle]. Xiao HJ; Liu JH Zhonghua Nan Ke Xue; 2003 Feb; 9(1):55-7. PubMed ID: 12680335 [TBL] [Abstract][Full Text] [Related]
25. Current status of calcium channel blockers in patients with cardiovascular disease. Freher M; Challapalli S; Pinto JV; Schwartz J; Bonow RO; Gheorgiade M Curr Probl Cardiol; 1999 May; 24(5):236-340. PubMed ID: 10340116 [No Abstract] [Full Text] [Related]
26. Calcium-channel antagonists in cardiovascular disease. Holdright DR Br J Hosp Med; 1997 Jun 4-17; 57(11):552-6. PubMed ID: 9307671 [TBL] [Abstract][Full Text] [Related]
28. [Calcium antagonists in the treatment of heart diseases]. Hess OM; Hirzel HO; Krayenbühl HP Schweiz Med Wochenschr; 1982 May; 112(19):689-92. PubMed ID: 7201672 [TBL] [Abstract][Full Text] [Related]
29. [Calcium antagonists in the treatment of heart failure. Re-evaluation of therapeutic strategies]. Gattis W; O'Connor CM Drugs; 2000; 59 Spec No 2():17-24. PubMed ID: 11002855 [TBL] [Abstract][Full Text] [Related]
30. Actions of calcium channel blockers on vascular proteoglycan synthesis: relationship to atherosclerosis. Survase S; Ivey ME; Nigro J; Osman N; Little PJ Vasc Health Risk Manag; 2005; 1(3):199-208. PubMed ID: 17319105 [TBL] [Abstract][Full Text] [Related]
31. Calcium antagonism: a new approach. Nayler WG Clin Exp Pharmacol Physiol Suppl; 1982; 6():3-13. PubMed ID: 6288293 [TBL] [Abstract][Full Text] [Related]
32. The use of calcium-channel blockers in pregnancy. Lewis R; Sibai BM New Horiz; 1996 Feb; 4(1):115-22. PubMed ID: 8689266 [TBL] [Abstract][Full Text] [Related]
34. Amlodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease. Murdoch D; Heel RC Drugs; 1991 Mar; 41(3):478-505. PubMed ID: 1711448 [TBL] [Abstract][Full Text] [Related]
35. Use of calcium channel blockers in hypertension. Conlin PR; Williams GH Adv Intern Med; 1998; 43():533-62. PubMed ID: 9506192 [TBL] [Abstract][Full Text] [Related]
36. Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future? Dahlöf B; Devereux RB; Kjeldsen SE; Lyle PA; Zhang Z; Edelman JM Blood Press; 2007; 16(1):6-12. PubMed ID: 17453746 [TBL] [Abstract][Full Text] [Related]
37. Calcium channels and calcium channel blockers. Seth SD; Seth S Indian J Physiol Pharmacol; 1991 Oct; 35(4):217-31. PubMed ID: 1667398 [No Abstract] [Full Text] [Related]
38. [Calcium antagonists: current and future applications based on new evidence. Effects of calcium channel blockers on oxidative stress]. Nishiyama A; Nakano D; Hitomi H Clin Calcium; 2010 Jan; 20(1):38-44. PubMed ID: 20048432 [TBL] [Abstract][Full Text] [Related]
39. How safe are calcium channel antagonists. Birbari AE J Med Liban; 1995; 43(3):120-1. PubMed ID: 8965311 [No Abstract] [Full Text] [Related]